SBL
SPPI

Sargent Bickham Lagudis’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Sargent Bickham Lagudis’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-100
Closed – – 1163
2022
Q1 		$0 Hold
100
– – ﹤0.01% 1042
2021
Q4 		$0 Hold
100
– – ﹤0.01% 1036
2021
Q3 		$0 Hold
100
– – ﹤0.01% 1012
2021
Q2 		$0 Hold
100
– – ﹤0.01% 1021
2021
Q1 		$0 Hold
100
– – ﹤0.01% 999
2020
Q4 		$0 Hold
100
– – ﹤0.01% 929
2020
Q3 		$0 Hold
100
– – ﹤0.01% 847
2020
Q2 		$0 Buy
+100
New +$291 ﹤0.01% 836
2016
Q3 		– Sell
-3,000
Closed -$5K – 788
2016
Q2 		$5K Hold
3,000
– – ﹤0.01% 615
2016
Q1 		$5K Buy
+3,000
New +$15.4K ﹤0.01% 636

Other funds holding SPPI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Sargent Bickham Lagudis's SPPI Position: Q2 2022 in Review

Sargent Bickham Lagudis sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q2 2022, closing a stake of 100 shares.

Sargent Bickham Lagudis first reported a position in SPPI in Q1 2016 and held it in 10 quarters. The position peaked at $5K in Q2 2016. 86 funds tracked by Wall St. Rank hold SPPI as of Q2 2022.

  • Sargent Bickham Lagudis reported no remaining Spectrum Pharmaceuticals Inc position as of Q2 2022 after selling out during the quarter.
  • Sargent Bickham Lagudis sold 100 Spectrum Pharmaceuticals Inc shares in Q2 2022.
  • Sargent Bickham Lagudis first reported a position in Spectrum Pharmaceuticals Inc in Q1 2016 and held it in 10 quarters.
  • Sargent Bickham Lagudis's Spectrum Pharmaceuticals Inc position peaked at $5K in Q2 2016.
  • 86 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q2 2022.

Based on Sargent Bickham Lagudis's 13F filing for Q2 2022, filed 13 Jul 2022.